Regeneus Ltd. (AU:CMB) has released an update.
Apex Metro Investments Limited experienced a dilution in its voting power in Cambium Bio Limited, from 9.03% to 5.8%, following the issuance of shares on June 28, 2024. This change occurred without any associated change in the number of shares held, which remained at 69,157,904. The dilution resulted from a placement announced earlier on April 5, 2024.
For further insights into AU:CMB stock, check out TipRanks’ Stock Analysis page.
